For researchers

Research at CMM

The focus of CMM research has since the beginning been common and currently chronic diseases. Many of these diseases, including rheumatic diseases, psoriasis, MS, cardiovascular diseases and neuropsychiatric diseases such as depression and drug addiction can today be studied and understood using a combination of clinical investigation and modern bioscience present at CMM.
Sweden´s health care system, CMM:s proximity to the clinical care units and its equal proximity to basic science units at Karolinska Institutet have created an internationally unique opportunity to understand the origins, diseases mechanisms and outcomes of these diseases, and thus also new opportunities to develop prevention and targeted therapies. Our strategy is also to combine competence from the 28 research groups of CMM to foster interdisciplinary research, for example regarding understanding of how inflammation may lead to cardiovascular disease (a Linnaeus center embedded in CMM is studying this problem) and how the immune system interacts with the brain.


Upcoming steering group meeting 140820

The next steering group meeting takes place on Wednesday the 20th of August between 12-14 in the VIP room at L8:05.


Back to work

Everyone working at CMM are most welcome to our annual summer coffee, which is called ‘Back to work’ since it is taking place after the summer this year.

Friday the 22nd of August at 14:30, floor 5 we will serve coffee and cake.

See you there!


METACORE TRAINING

KI library now offers MetaCore, an integrated software suite for functional analysis of experimental data. MetaCore is based on a curated database of human protein-protein, protein-DNA interactions, transcription factors, signaling and metabolic pathways, disease and toxicity, and the effects of bioactive molecules. Use MetaCore for functional analysis of gene expression, proteomics, metabolomics, siRNA, SNPs and HCS.
To use this software at KI library, use this link for information and account application.

Metacore Training Availability:

There is a series of training sessions lined up; the first will take place on Wednesday 27 August at KIB.
This is your opportunity to ask Thomson Reuters expert trainers your questions in person.
Places are limited so please secure your place by email to: Vikram.rao@thomsonreuters.com

Location: Room U2, Karolinska Institutet, Univeristy Library, Campus Solna
Address: Berzelius väg 7B (link to map)

metacore

Training session:

Wednesday, 27 August
Draft agenda (to be confirmed):
0900: Registration and log in
0930: Introduction to MetaCore, data upload, basic analysis, network building
1100: Hands-on workshop with trainer support
1230: End of group session, break for lunch
1330 – 1730: Individual / small group sessions, to be booked in advance.

Please advise if you would like an individual session in the afternoon.

You can address any questions to : Vikram.rao@thomsonreuters.com


Magnus Bäck new group leader at CMM

Magnus Bäck is doing research on lipid mediators in atherosclerosis. Bck_Magnus_Main


Anna Fogdell-Hahn new group leader at CMM

Anna Fogdell-Hahn_220

Anna Fogdell-Hann conducts research on viruses and autoimmunity.
Visit group page.

 

 


THE ACADEMICS BIGGEST UNTRUTH – I DON’T HAVE TIME!

white rabbitEditorial: How often do you hear scientists say “I’m a bit stressed, I’m afraid I don’t have time just now”. A common excuse for supervisors and students not spending time discussing science, for refusing participation  in a half-time review or passing on the opportunity to review a journal manuscript. My mother always encouraged me not to tell untruths, and in recent years I’ve pondered why we allow and even tolerate this common practice? Isn’t it time for honesty? Next time you feel you’re becoming the Disney White Rabbit, try saying “I’m sorry, but I don’t prioritise you”, as that’s really the truth. Read more

.


Upcoming board meeting

The last CMM board meeting of the year takes place the 11th of december between 15-18.


New group leader at CMM

hans-gronlundAt the steering group meeting the 2nd of december it was decided that Hans Grönlund, leader for Therapeutic Immune design becomes a new group leader at CMM. Hans’ group conducts research on asthma and allergies.


Next steering group meeting

The next steering group meeting takes place at the 2nd of December between 13-16 in the VIP room at L8:05


The ‘red thread’ is a potential noose on creativity

Editorial: Joseph Schumpeter first defined the term ‘creative destruction’ (Capitalism, Socialism, and Democracy, 1942), hypothesizing that economic capitalism induces entrepreneurship, with associated technological progress being dependent on ‘wild spirited individuals.’ This entrepreneurial spirit yields a gale of creative destruction through disruptive inventions and innovations that changes the status quo.

Innovation is considered central to the dynamics and success of organizations. Innovation (1) involves change; (2) must be genuinely interdisciplinary; (3) international; and (4) must reflect the fundamental changes taking place in science, research and knowledge creation at all levels (Hage & Meeus: Innovation, Science, and Institutional Change: A Research Handbook; 2009).

So if we agree that innovation is essential for technological development, how is innovation currently rewarded in medical science? Read more


CMM Research Groups

NEUROGENETICS AND PSYCHIATRIC DISEASES

GENETIC DISEASES

INFLAMMATORY DISEASES

Cardiovascular and Metabolic Diseases